Palatin Technologies
PTN
#9923
Rank
HK$0.30 B
Marketcap
HK$179.04
Share price
4.59%
Change (1 day)
2,374.01%
Change (1 year)

Earnings for Palatin Technologies (PTN)

Earnings in 2025 (TTM): -HK$0.14 Billion

According to Palatin Technologies's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -HK$0.21 Billion, an increase over its 2023 earnings that were of -HK$0.26 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Palatin Technologies from 1998 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -HK$0.14 Billion-35.81%
2024 -HK$0.21 Billion-16.9%
2023 -HK$0.26 Billion5.99%
2022 -HK$0.24 Billion-13.7%
2021 -HK$0.28 Billion33.25%
2020 -HK$0.21 Billion-172.11%
2019 HK$0.28 B2352.33%
2018 HK$11.7 M-94.13%
2017 HK$0.19 B-154.92%
2016 -HK$0.37 Billion3.67%
2015 -HK$0.36 Billion878%
2014 -HK$35.83 Million-72.64%
2013 -HK$0.14 Billion-33.11%
2012 -HK$0.2 Billion77.71%
2011 -HK$0.12 Billion
2003 -HK$0.19 Billion29.93%
2002 -HK$0.15 Billion36.18%
2001 -HK$0.11 Billion
1999 -HK$87.5 Million6.04%
1998 -HK$82.52 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
MediciNova
MNOV
-HK$91.91 Million-31.72%๐Ÿ‡บ๐Ÿ‡ธ USA
GlycoMimetics
GLYC
-HK$0.23 Billion 70.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
HK$4.53 B-3,472.60%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
HK$0.39 B-392.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
HK$0.51 B-486.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-HK$0.92 Billion 580.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
HK$252.18 B-187,443.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
-HK$0.44 Billion 221.24%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
HK$101.89 B-75,798.43%๐Ÿ‡ฌ๐Ÿ‡ง UK